|
KITE-363 Clinical Trials
1 actively recruiting trial across 1 location
No change since September 2026
Pipeline
Phase 1: 1
Top Sponsors
- Kite, A Gilead Company1
Indications
- Chronic Inflammatory Demyelinating Polyneuropathy1
- Multiple Sclerosis1
- Myasthenia Gravis1
- Cancer1
Newport Beach, California1 trial
Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
Hoag Memorial Hospital Presbyterian
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.